Suchergebnisse - "Berry, Donald A"

PubPharm (417)

1

Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients – An Observational Study

enthalten in: bioRxiv.org | 2024

von Ip, A. | Berry, D. | Hansen, E. | +29

2

A Cost/Benefit Analysis of Clinical Trial Designs for COVID-19 Vaccine Candidates

enthalten in: bioRxiv.org | 2024

von Berry, D. | Berry, S. | Hale, P. | +4

3

Pathologic response in resectable non-small cell lung cancer : a systematic literature review and meta-analysis

enthalten in: JNCI cancer spectrum | 2024

von Waser, N. | Quintana, M. | Schweikert, B. | +8

4

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Albain, K. | Yau, C. | Petricoin, E. | +46

5

Analysis of Breast Cancer Mortality in the US-1975 to 2019

enthalten in: JAMA | 2024

von Caswell-Jin, J. | Sun, L. | Munoz, D. | +16

CommentIn: JAMA. 2024 Jan 16;331(3):199-200. - PMID 38227044

6

Lecanemab for Patients With Early Alzheimer Disease : Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Berry, D. | Dhadda, S. | Kanekiyo, M. | +5

7

PET-CR as a potential surrogate endpoint in untreated DLBCL : meta-analysis and implications for clinical trial design

enthalten in: Leukemia & lymphoma | 2022

von Broglio, K. | Kostakoglu, L. | Ward, C. | +14

8

Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia : a systematic review and meta-analysis

enthalten in: Leukemia | 2022

von Short, N. | Fu, C. | Berry, D. | +10

9

Evaluation of cell-free DNA approaches for multi-cancer early detection

enthalten in: Cancer cell | 2022

von Jamshidi, A. | Liu, M. | Klein, E. | +46

10

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease

enthalten in: Alzheimer's research & therapy | 2022

von Dhadda, S. | Kanekiyo, M. | Li, D. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]